Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDent, J.-
dc.contributor.authorTalley, N.-
dc.identifier.citationAlimentary Pharmacology and Therapeutics, 2003; 17(1):53-57-
dc.descriptionArticle first published online: 4 MAR 2003-
dc.description.abstractInitial management of gastro-oesophageal reflux disease aims to confirm a symptom-based diagnosis, to relieve symptoms, to reassure the patient as to the treatable nature of reflux disease, and to initiate risk management and healing of oesophagitis. The aims of long-term management include adequate control of symptoms, prevention of complications, and improvement of quality of life. Management options in terms of use of proton pump inhibitors are either daily therapy (maintenance), intermittent courses of therapy (for example, 4 weeks, then cease and observe), or on-demand therapy. This overview discusses the advantages and disadvantages of these different strategies for the management of reflux disease.-
dc.description.statementofresponsibilityJ. Dent & N. J. Talley-
dc.publisherBlackwell Publishing Ltd-
dc.rights© 2003 Copyright Blackwell Publishing Ltd-
dc.subjectGastroesophageal Reflux-
dc.subjectTreatment Failure-
dc.subjectLong-Term Care-
dc.subjectRisk Factors-
dc.subjectDecision Making-
dc.subjectRisk Management-
dc.subjectProton Pump Inhibitors-
dc.titleOverview: initial and long-term management of gastro-oesophageal reflux disease-
dc.typeJournal article-
Appears in Collections:Aurora harvest
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.